ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Methoxsalen
  • indication:For the treatment of psoriasis and vitiligo
  • pharmacologypharmacology:
  • mechanism: After activation it binds preferentially to the guanine and cytosine moieties of DNA, leading to cross-linking of DNA, thus inhibiting DNA synthesis and function.
  • toxicity:
  • absorprion:
  • halflife: Approximately 2 hours
  • roouteelimination: In both mice and man, methoxsalen is rapidly metabolized. Approximately 95% of the drug is excreted as a series of metabolites in the urine within 24 hours (Pathak et al. 1977).
  • volumedistribution:
  • clearance: